LEKARKA Co.,Ltd.

Since its establishment in 2017, Lekarka Co., Ltd. has operated under the mission to "Transform the Future Through the Experience of Becoming Beautiful," offering the medical-grade skincare brand "DREX" and the skincare brand "Lekarka." Driven by a relentless pursuit of "tangible results" from research and development to product delivery, the company supports the lasting beauty customers desire, aiming to enrich the lives of everyone who encounters Lekarka.

Furthermore, starting in September 2026, Lekarka will serve as the official distributor in Japan for "KLOSOME®," a novel exosome formulation containing the longevity protein Klotho, which has recently drawn global attention. Through this initiative, the company strives to promote new value across the cutting-edge beauty and medical fields nationwide.